Acute Diabetes Complications After Transition to a Value-Based Medication Benefit.

ABSTRACT:

Importance

The association of value-based medication benefits with diabetes health outcomes is uncertain.

Objective

To assess the association of a preventive drug list (PDL) value-based medication benefit with acute, preventable diabetes complications.

Design, setting, and participants

This cohort study used a controlled interrupted time series design and analyzed data from a large, national, commercial health plan from January 1, 2004, through June 30, 2017, for patients with diabetes aged 12 to 64 years enrolled through employers that adopted PDLs (intervention group) and matched and weighted members with diabetes whose employers did not adopt PDLs (control group). All participants were continuously enrolled and analyzed for 1 year before and after the index date. S

SUBMITTER: Wharam JF 

PROVIDER: S-EPMC10858396 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature